Rick Doblin founded the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986, as a “non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.”*. As a non-profit, MAPS is an unlikely player in a drug-development field dominated by big pharma and … Read More »
Blog
Guest on the Kannaboom Podcast
It was a great to be able to speak about my work on the Kannaboom podcast – You can hear it here! https://kannaboom.com/47-abbie-rosner-cannabis-journalist
Psychedelic Drugs Can Improve Quality Of Life – And Death – For Older Adults
Even before COVID-19 set off a global tsunami of anxiety and depression, psychedelic drugs were already showing exciting promise for treating these and other intractable mental health conditions. Compass Pathway’s recent raise of $80M to expand research into the clinical uses of psilocybin only affirms that no coronavirus is going to dampen efforts to make … Read More »
Making Cannabis Medicine Available To The Isolated Elderly – Two Institutions Show It Can Be Done
Older adults – the population most vulnerable to the novel coronavirus – have plenty to be anxious about. Particularly for those residing in long-term care facilities, this stress can only be compounded. After COVID-19 swept through the Kirkland, Washington’s Life Care Center, and now appears to have spread to other nursing homes in the region, the vulnerability … Read More »
Microdosed LSD: Finally A Breakthrough For Alzheimer’s Disease?
(this article first appeared on Feb. 21, 2020) After decades of effort and untold millions invested in the search for an effective treatment for Alzheimer’s, the disease remains unchecked and rampant. Most recently, the New York Times reported that researchers declared defeat after the failure of yet another experimental drug designed to fight the formation of the … Read More »